3
Clinical Trials associated with Longya Guanxinkang Capsule龙牙冠心康胶囊治疗冠心病心绞痛(气虚血瘀证)Ⅲ期临床试验方案
[Translation] Phase III clinical trial plan of Longya Guanxinkang capsule in the treatment of angina pectoris (Qi deficiency and blood stasis syndrome) in coronary heart disease
对龙牙冠心康胶囊治疗冠心病心绞痛(气虚血瘀证)的临床疗效及安全性进行进一步评价。
[Translation] To further evaluate the clinical efficacy and safety of Longya Guanxinkang Capsule in the treatment of angina pectoris (Qi deficiency and blood stasis syndrome) caused by coronary heart disease.
龙牙冠心康胶囊治疗冠心病心绞痛(气虚血瘀证)Ⅱ期临床试验方案
[Translation] Phase II clinical trial plan of Longya Guanxinkang capsule in the treatment of angina pectoris (Qi deficiency and blood stasis syndrome) in coronary heart disease
对龙牙冠心康胶囊治疗冠心病心绞痛(气虚血瘀证)的临床用量,疗效及安全性进行初步探索及评价,确定Ⅲ期临床试验用量
[Translation] To conduct preliminary exploration and evaluation of the clinical dosage, efficacy and safety of Longya Guanxinkang Capsule in the treatment of angina pectoris (Qi deficiency and blood stasis syndrome) of coronary heart disease, and determine the dosage for Phase III clinical trial
[Translation] Phase I human tolerance trial of Longya Guanxinkang Capsule
观察人体对龙牙冠心康胶囊的反应及耐受程度。探索安全有效的用药剂量及合理给药方案,以指导Ⅱ期临床试验研究。
[Translation] To observe the human body's reaction and tolerance to Longya Guanxinkang Capsules. To explore safe and effective dosage and reasonable administration scheme to guide Phase II clinical trial research.
100 Clinical Results associated with Longya Guanxinkang Capsule
100 Translational Medicine associated with Longya Guanxinkang Capsule
100 Patents (Medical) associated with Longya Guanxinkang Capsule
100 Deals associated with Longya Guanxinkang Capsule